Literature DB >> 22282400

Identification of candidate genes carrying polymorphisms associated with the risk of colorectal cancer by analyzing the colorectal mutome and microRNAome.

Debora Landi1, Federica Gemignani, Barbara Pardini, Alessio Naccarati, Sonia Garritano, Pavel Vodicka, Ludmila Vodickova, Federico Canzian, Jan Novotny, Roberto Barale, Stefano Landi.   

Abstract

BACKGROUND: The presence of single-nucleotide polymorphisms (SNPs) within the 3'-untranslated regions of genes could affect the binding between a microRNA (miRNA) and its target, with consequences on gene expression regulation. Considering the important role of miRNAs in carcinogenesis, it is hypothesized here that these SNPs could also affect the individual risk of colorectal cancer (CRC).
METHODS: To test this hypothesis, a list was developed of 140 somatically mutated genes deduced from previous works on the mutome of the CRC. A further selection was conducted of SNPs within target sites for miRNAs that are expressed only in the colorectum (the colorectal microRNAome) and having adequate population frequencies. This yielded 12 SNPs that were genotyped in a case-control association study on 717 colorectal cases and 1171 controls from the Czech Republic.
RESULTS: Statistically significant associations were found between the risk of CRC and the variant alleles of KIAA0182 (rs709805) (odds ratio = 1.57; 95% confidence interval = 1.06-2.78, for the variant homozygotes) and NUP210 genes (rs354476) (odds ratio = 1.36; 95% confidence interval = 1.02-1.82, for the variant homozygotes).
CONCLUSIONS: The results support the study hypothesis and highlight the importance of SNPs within miRNA-dependent regulatory regions. Further studies on the role exerted by NUP210 and KIAA0182 in colorectal carcinogenesis are warranted.
Copyright © 2012 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22282400     DOI: 10.1002/cncr.27435

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

Review 1.  Early detection of colorectal cancer: from conventional methods to novel biomarkers.

Authors:  Nasimeh Vatandoost; Jahanafrooz Ghanbari; Mahboobeh Mojaver; Amir Avan; Majid Ghayour-Mobarhan; Reza Nedaeinia; Rasoul Salehi
Journal:  J Cancer Res Clin Oncol       Date:  2015-02-17       Impact factor: 4.553

2.  NEpiC: a network-assisted algorithm for epigenetic studies using mean and variance combined signals.

Authors:  Peifeng Ruan; Jing Shen; Regina M Santella; Shuigeng Zhou; Shuang Wang
Journal:  Nucleic Acids Res       Date:  2016-06-14       Impact factor: 16.971

3.  MicroRNA-19a targets tissue factor to inhibit colon cancer cells migration and invasion.

Authors:  Ge Yu; Hui Li; Xin Wang; Tao Wu; Jing Zhu; Shanjun Huang; Yuanlian Wan; Jianqiang Tang
Journal:  Mol Cell Biochem       Date:  2013-05-12       Impact factor: 3.396

4.  Single-nucleotide polymorphisms of microRNA processing machinery genes and risk of colorectal cancer.

Authors:  Yufei Zhao; Yanming Du; Shengnan Zhao; Zhanjun Guo
Journal:  Onco Targets Ther       Date:  2015-02-12       Impact factor: 4.147

Review 5.  MicroRNA binding site polymorphisms as biomarkers in cancer management and research.

Authors:  Monica Cipollini; Stefano Landi; Federica Gemignani
Journal:  Pharmgenomics Pers Med       Date:  2014-07-23

6.  Association between polymorphisms of TAS2R16 and susceptibility to colorectal cancer.

Authors:  Jonathan Barontini; Marco Antinucci; Sergio Tofanelli; Maurizio Cammalleri; Massimo Dal Monte; Federica Gemignani; Pavel Vodicka; Roberto Marangoni; Ludmila Vodickova; Juozas Kupcinskas; Veronika Vymetalkova; Asta Forsti; Federico Canzian; Angelika Stein; Victor Moreno; Nicola Mastrodonato; Francesca Tavano; Anna Panza; Roberto Barale; Stefano Landi; Daniele Campa
Journal:  BMC Gastroenterol       Date:  2017-09-15       Impact factor: 3.067

7.  MicroRNA-binding site polymorphisms and risk of colorectal cancer: A systematic review and meta-analysis.

Authors:  Morteza Gholami; Bagher Larijani; Farshad Sharifi; Shirin Hasani-Ranjbar; Reza Taslimi; Milad Bastami; Rasha Atlasi; Mahsa M Amoli
Journal:  Cancer Med       Date:  2019-10-21       Impact factor: 4.452

8.  miR‑647 and miR‑1914 promote cancer progression equivalently by downregulating nuclear factor IX in colorectal cancer.

Authors:  Shaoqing Liu; Dingding Qu; Weiping Li; Chenxiang He; Shisen Li; Guosheng Wu; Qingchuan Zhao; Liangliang Shen; Jian Zhang; Jianyong Zheng
Journal:  Mol Med Rep       Date:  2017-09-29       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.